Patents by Inventor Minmin Wang

Minmin Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic Compound and Preparation Method and Use Thereof
    Publication number: 20230406829
    Abstract: Disclosed are a heterocyclic compound for an immune checkpoint inhibitor capable of blocking a VISTA signaling pathway, and a preparation method therefor and a use thereof. The compound is as represented by formula I. The compound has a novel structure, can be formulated for oral administration, overcomes the treatment defects and drug resistance of monoclonal antibody-based immune checkpoint inhibitors, can be used to prepare a small molecule inhibitor easily, and is convenient for industrial production.
    Type: Application
    Filed: August 27, 2021
    Publication date: December 21, 2023
    Inventors: Sheng Jiang, Yibei Xiao, Tianyu Wang, Yu Zhang, Haiping Hao, Minmin Wang, Kuojun Zhang, Yatao Qiu
  • Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
    Patent number: 7728150
    Abstract: The present invention provides a compound of the formula: Formula (I); or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising an effective amount of a compound of Formula I in combination with a suitable carrier, diluent, or excipient, and methods for treating physiological disorders, particularly congestive heart disease, hypertension, and atherosclerosis, comprising administering to a patient in thereof an effective amount of a compound of Formula I.
    Type: Grant
    Filed: February 18, 2005
    Date of Patent: June 1, 2010
    Assignee: Eli Lilly and Company
    Inventors: Konstantinos Gavardinas, Prabhakar Kondaji Jadhav, Minmin Wang
  • Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
    Publication number: 20070185161
    Abstract: The present invention provides a compound of the formula: Formula (I); or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising an effective amount of a compound of Formula I in combination with a suitable carrier, diluent, or excipient, and methods for treating physiological disorders, particularly congestive heart disease, hypertension, and atherosclerosis, comprising administering to a patient in thereof an effective amount of a compound of Formula I.
    Type: Application
    Filed: February 18, 2005
    Publication date: August 9, 2007
    Inventors: Konstantinos Gavardinas, Prabhakar Jadhav, Minmin Wang
  • Peroxisome proliferator activated receptor modulators
    Publication number: 20070082907
    Abstract: The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
    Type: Application
    Filed: November 16, 2004
    Publication date: April 12, 2007
    Applicant: ELI LILLY AND COMPANY
    Inventors: Emily Canada, Lynn Gossett, Nathan Mantlo, Qing Shi, Minmin Wang, Alan Warshawsky, Yanping Xu
  • Ppar modulators
    Publication number: 20060257987
    Abstract: The present invention is directed to a compound of formula I, or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
    Type: Application
    Filed: August 17, 2004
    Publication date: November 16, 2006
    Inventors: Isabel Cristina Gonzalez Valcarcel, Nathan Mantlo, Qing Shi, Minmin Wang, Leonard Winneroski, Yanping Xu, Jeremy York
  • Nonpeptide agonists and antagonists of vasopressin receptors
    Publication number: 20020128208
    Abstract: The disclosed invention is a composition agonists and/or antagonists of V2, V1a or both receptors, in a host, including animals, and especially humans, using a small molecule or its pharmaceutically acceptable salt or prodrug.
    Type: Application
    Filed: December 17, 2001
    Publication date: September 12, 2002
    Inventors: James P. Snyder, Dennis C. Liotta, Hariharan Venkatesan, Minmin Wang, Matthew C. Davis